Tumour development following immunosuppression.
D000328:Adult; D000818:Animals; D000961:Antilymphocyte Serum; D001379:Azathioprine / Q000009:adverse effects; D002648:Child; D006224:Cricetinae; D005260:Female; D006801:Humans; D007111:Immunity, Cellular; D007153:Immunologic Deficiency Syndromes / Q000150:complications; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D016030:Kidney Transplantation; D007942:Leukemia, Experimental / Q000209:etiology; D016403:Lymphoma, Large B-Cell, Diffuse / Q000209:etiology; D051379:Mice; D008979:Moloney murine leukemia virus; D009369:Neoplasms / Q000209:etiology*; D009374:Neoplasms, Experimental / Q000276:immunology; D011120:Polyomavirus; D013539:Simian virus 40; D014184:Transplantation, Homologous; D014777:Virus Diseases / Q000209:etiology
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D001379:Azathioprine